Gennex Laboratories shareholding pattern

GENNEX

11.69

0.12 (-1.02%)
Last updated on 20 Feb, 2026 | 15:47 IST
alert_iconwatchlist_icon
BUYSELL
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Gennex Laboratories Shareholding Pattern

  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

23.62%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

76.38%

Others

0%

Total Promoters
MAR '25
18.42%
JUN '25
19.83%
SEP '25
23.62%
DEC '25
23.62%

Summary

For Year 2025-26, Gennex Laboratories reports the following shareholding: Total Promoters at 23.62%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 76.38%. This breakdown provides a quick snapshot of ownership distribution for Gennex Laboratories in 2025-26.

Gennex Laboratories FAQs

As of 02-2026, the promoter shareholding in Gennex Laboratories stands at 23.62% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Gennex Laboratories is 0% and 0% respectively.

The retail shareholding of the Gennex Laboratories is 76.38%.

Changes in shareholding patterns of Gennex Laboratories can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Gennex Laboratories are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost